|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.63/-1.69
|
企业价值
405.49M
|
资产负债 |
每股账面净值
1.15
|
现金流量 |
现金流量率
--
|
损益表 |
收益
3.60M
|
每股收益
0.11
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 01:07 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. |